Back to Rankings

NKTR

Nektar TherapeuticsD
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-06-11
View Chart
+
Peers tracked
11
U.S. public peers
Grade Position
Below peers
vs peer average
NKTR vs peer average
44/100
NKTR vs. peer average (D vs. D)
Grade spread
B 2 · C 2 · D 5 · F 2
Graded peers loaded
Coverage
11 graded
100% of tracked

Peer overview

CMPX is the first available peer comparator.

Early-stage oncology/biotech peer with similar dependence on clinical updates and financing sentiment, though not an indication match.

Peer source comes from the stored AI memo or peer model
Grades and factor rows use RankAlpha API data when available
Missing peer scores remain blank instead of being estimated
Side-by-side comparison keeps the data contract visible
Top peerCMPXCompass Therapeutics
NKTR
Nektar Therapeutics
CMPX
Compass Therapeutics
Grade
D
D
Momentum
6
35
Value
41
41
Sentiment
77
47
Setup Bias
Net Neutral
-
Market Cap
-
-
Posture
Defensive
Defensive

Grade position vs CMPX

NKTR / CMPX
Grade Position
Below peers
NKTR vs. peer average (D vs. D)
44/100
Momentum
6
CMPX
Value
41
NKTR
Sentiment
77
NKTR

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs NKTR
1
CMPX
CMPX
D
40/100
Even
2
ELVN
ELVN
C
60/100
-1
3
ESPR
ESPR
B
80/100
-2
4
TRVI
Trevi Therapeutics Inc Common
D
40/100
Even
5
BHC
Bausch Health Companies Inc Common
D
40/100
Even
CMPX is the first peer returned for this comparison set.